Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.
| Website: | www.nevro.com |
| Email: | ir@nevro.com |
| Main Phone: | +1 650 251-0005 |
| Address: | 1800 Bridge Parkway |
| Address 2: | Redwood City |
| State: | CA |
| City / Town: | Redwood City |
| Country: | USA |
| Postal Code: | 94065 |
| Exchange: | NYE |
| CEO: | D. Keith Grossman |
| Employees: | 853 |
| NAICS: | Electromedical and Electrotherapeutic Apparatus Manufacturing(334510) |
Nevro ($NVRO) is a medical device company that has developed and commercialized an innovative neuromodulation platform for the treatment of chronic pain. It is based in Menlo Park, CA. Tenother
Full IPO calendar & reports HERE. In order of largest IPO first. (1) Based in Denver, CO,Antero Midstream Partners LP (AM) scheduled a $750 million IPO on NYSE with a market
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.
| Website: | www.nevro.com |
| Email: | ir@nevro.com |
| Main Phone: | +1 650 251-0005 |
| Address: | 1800 Bridge Parkway |
| Address 2: | Redwood City |
| State: | CA |
| City / Town: | Redwood City |
| Country: | USA |
| Postal Code: | 94065 |
| Exchange: | NYE |
| CEO: | D. Keith Grossman |
| Employees: | 853 |
| NAICS: | Electromedical and Electrotherapeutic Apparatus Manufacturing(334510) |
Nevro ($NVRO) is a medical device company that has developed and commercialized an innovative neuromodulation platform for the treatment of chronic pain. It is based in Menlo Park, CA. Tenother
Full IPO calendar & reports HERE. In order of largest IPO first. (1) Based in Denver, CO,Antero Midstream Partners LP (AM) scheduled a $750 million IPO on NYSE with a market
| Last Price 114.09 | Change $ -0.49 | Change % -0.43 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 114.75 | High 114.77 | Low 112.20 | Prev Close 114.58 |
| Last Trade | Volume 279,787 | 52 Wk Hi 148.06 | 52 Wk Low 60.51 |
| Market Cap 3.9 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 33,998,250.00 | EPS (TTM) -2.71 | PE Ratio N/A | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 12 | 81 |
| Number of Buys | 9 | 23 |
| Number of Sells | 3 | 58 |
| Net Activity | 21843 | -299241 |
| Last 10 Buys | Shares |
|---|---|
| Brad Vale | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Andrew Galligan | 1,000 |
| Wilfred E. Jaeger | 1,000 |
| Wilfred E. Jaeger | 1,000 |
| Wilfred E. Jaeger | 1,000 |
| Wilfred E. Jaeger | 1,000 |
| Wilfred E. Jaeger | 1,000 |
| Wilfred E. Jaeger | 1,000 |
| Wilfred E. Jaeger | 1,000 |
| Wilfred E. Jaeger | 1,000 |
| Andrew Galligan | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 105 | 105 | 105 | 105 |
| Low Target Price Estimate | 80 | 80 | 80 | 80 |
| Mean Target Price Estimate | 95 | 95 | 95 | 95 |
| Standard Deviation | 8.9 | 8.9 | 8.9 | 8.9 |
| Date of Most Recent Estimate | 05/28/18 | 05/28/18 | 05/17/18 | 05/28/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| SD | Specialized Disclosure Report | 5 | 2018-05-31 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-05-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 9 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.44 | 1.44 | 1 | 1 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait